VRTX is trading at $523.24, up 5.1% versus the comparison close of $498.01 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this alert.
🟢 VRTX extends move to 5.1% up
Vertex Pharmaceuticals Inc
Related News
VRTX
Vertex's IgAN Drug Cuts Proteinuria 52%; FDA Decision Due Nov. 30, 2026
VRTX
Vertex Reports VX-548 Hits Phase 3 Goal for Diabetic Nerve Pain
VRTX
🔴 Vertex Pharmaceuticals is trading 5% down in pre-market with no clear company-specific catalyst identified
VRTX
🟢 Vertex Pharmaceuticals is trading 4.3% up in pre-market amid a reported Wall Street Zen upgrade
VRTX